Phase II multicenter study of immuno-chemotherapy with fludarabine, cyclophosphamide and rituximab (FCR) for symptomatic Waldenstrom's macroglobulinemia

Registry ID

EUCTR2005-000174-52

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

ASSOCIAZIONE MALATTIE SANGUE

Start date

2005-01-11

Last update

2026-08-16

Conditions

• Waldenstrom's macroglobulinemia

Summary

Waldenstrom's macroglobulinemia

Locations

• , , Italy

View on source registry